Pharma raises its bet on biotech

Hundreds of years ago, across Europe - from Germany to Scandinavia, France to Britain - tens of thousands of mostly women were executed, accused of being witches. The persecution reached its height in the 16th and 17th centuries. But why? And could economics help explain the hyst ...  Show more

The French Revolution was a bloody fight for liberty, equality and fraternity. But it was also a battle over money.In part two of our series on the French Revolution, host Robin Wigglesworth tackles the transformation of France’s monetary system with Rebecca Spang, historian and ...  Show more

Apple & Amazon the latest big tech names to report results. The headlines from the company conference calls, and what top tech analyst Gene Munster sees in store for the group. Plus Eli Lilly jumping as its obesity drug sales soar. How the company is moving the needle in the w ...

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billi ...  Show more

Laura Chico, Biotechnology Research Analyst at Wedbush Securities and Bloomberg News US Deals Team Leader Matthew Monks share their thoughts on the Bristol Myers acquisition Karuna Therapeutics. John Mowrey, CIO at NFJ Investment Group, explains where to find value in the markets ...  Show more